Salventis
Innovative Care  ·  Trusted Quality
🔔 Salventis Pharma is ready to serve you — anytime, any day. Hospital procurement, partnerships & enquiries welcome. Click Here →
📞 +92 300 8255019
☎ +92 51 6108078
✉ info@salventispharma.com
DRAP Registered
🇵🇰 Islamabad, Pakistan
Home Vision & Mission About Us Roadmap Leadership Medicines Careers News Contact Enquire Now →
Islamabad · Pakistan

Specialist Medicines That
Protect & Heal

Innovative Care. Trusted Quality.

We exist to make life-saving specialty medicines accessible — reliably, affordably, with the clinical integrity Pakistan's patients deserve.

Discover Our Medicines → Get In Touch
3+
Therapeutic Areas
7+
Specialty Products
50+
Years Leadership
🧬
Flagship Division
Oncology
Zoledronic Acid · Zolegen® · Bisphosphonates
🏥
Division
Urology
Tamstone-D · Tamstone
🔬
Division
Critical Care
Meropenem · Tigradox
Division
Radiology
Iohexol · Contrast Agents
🏛️DRAP Registered
🌡️Cold Chain Certified
⚗️WHO-GMP Sourced
🧬Oncology · Urology · Critical Care · Radiology
🇵🇰Islamabad, Pakistan
🔗Verified Import Channels
💊Specialty Pharmaceutical Distribution
🏛️DRAP Registered
🌡️Cold Chain Certified
⚗️WHO-GMP Sourced
🧬Oncology · Urology · Critical Care · Radiology
🇵🇰Islamabad, Pakistan
🔗Verified Import Channels
💊Specialty Pharmaceutical Distribution
Our Purpose

Vision & Mission

Science-driven. Patient-centred. Built to make life-saving medicines accessible across Pakistan.

✦ Our Vision

To be Pakistan's most trusted partner in bringing life-saving medicines to every patient.

Salventis Pharma aspires to be the definitive bridge between global pharmaceutical innovation and Pakistan's healthcare system — recognised by clinicians, institutions, and patients as the standard of excellence in specialty pharmaceutical distribution. By 2030, Salventis will have established itself as the partner of choice for international pharmaceutical principals seeking credible, compliant, and commercially capable representation in Pakistan.

✦ Our Mission

To introduce high-quality, innovative therapies that meaningfully improve patient outcomes.

Sourcing with integrity — partnering exclusively with reputable manufacturers who share our commitment to quality and compliance.
Distributing with precision — maintaining cold-chain integrity, DRAP registration, and WHO-GMP standards at every step.
Engaging with expertise — leveraging deep therapeutic knowledge to deliver meaningful clinical value to healthcare professionals.
What We Stand For

Core Values

01🔬
Scientific Integrity

Every product decision grounded in clinical evidence. Science-driven commercialisation — never compromising quality for commercial gain.

02🤝
Patient-Centred Purpose

We measure success in patient outcomes — every therapy represents a life touched, a condition managed, a family supported.

03🏛️
Regulatory Excellence

Full DRAP compliance and international regulatory expertise are foundational — not optional. We navigate complex frameworks to ensure safe, reliable delivery.

04🌍
Global Partnerships

Strategic alliances with reputable international manufacturers — bringing monoclonal antibodies and specialty diagnostics into the Pakistani market.

05⚙️
Operational Excellence

Cold-chain integrity, on-time delivery, and supply reliability are operational standards — not aspirations. We deliver what we promise.

06💡
Long-Term Value Creation

Building lasting value for healthcare institutions, principal partners, distribution networks, and the patients whose lives depend on innovative therapies.

Salventis pharmaceutical laboratory
We Are Salventis
Our Mission In Action

Doing Now What Patients
Need Next

From Islamabad to every hospital and clinic across Pakistan — our medicines are making a measurable difference in patient lives, one vial at a time.

Hospital care
01
🏥
Hospital-Grade Access

We bring carbapenem antibiotics, bisphosphonates, and contrast agents to hospitals, ICUs, and oncology centres that need them most — at prices that enable institutional procurement.

Learn about Critical Care →
Oncology research
02
🧬
Oncology for Pakistan

Zoledronic Acid and Zolegen® reach oncologists and bone specialists across the country — providing WHO Essential Medicine access at prices that make treatment viable for more patients.

Learn about Oncology →
Strategic partnership
03
🤝
Strategic Partnerships

Actively seeking international collaborations in oncology, radiology, and specialty therapeutics — including monoclonal antibodies — to expand Pakistan's access to cutting-edge pharmaceutical innovations.

Explore Partnerships →
Our Growth Roadmap

Expanding Therapeutic Horizons

From three active divisions today to a comprehensive specialty portfolio — here is our path forward.

🧬
Active Now
Oncology & Urology

Zoledronic Acid, Zolegen®, Tamstone-D & Tamstone — serving oncologists and urologists nationwide.

● Live
🏥
Active Now
Critical Care

Meropenem (1g & 500mg) and Tigradox — hospital-grade IV antibiotics for ICU & emergency settings.

● Live
📡
Q4 2026
Radiology

Iohexol & contrast imaging agents — expanding into diagnostic radiology across Pakistan's hospitals.

◐ Launching Q4 2026
❤️
2027
Cardiology

Cardiovascular specialty portfolio under active development — addressing Pakistan's leading cause of mortality.

○ Coming 2027
Founding Leadership

The Experience Behind
Salventis Pharma

👤
Zillur Rahman Qureshi
Founder & Chief Executive Officer
Salventis Pharma (SMC-Private) Limited
🎓 MBA — Marketing
📅 50+ Years Experience
🌍 Multinational Leadership

"A firm believer in ethical, science-driven commercialisation — with a consistent focus on innovation, operational excellence, and long-term value creation."

Zillur Rahman Qureshi brings over 50 years of distinguished pharmaceutical leadership across multinational and leading local organisations in Pakistan and internationally. Holding an MBA in Marketing complemented by extensive executive training in strategic planning, portfolio management, and international business.

His executive career spans C-suite and board-level roles — including Managing Director, Chief Operating Officer, and Director of Marketing — with landmark contributions to Sanofi Aventis and Boehringer Mannheim, as well as leading pharmaceutical groups across Pakistan.

Therapeutic Expertise
Oncology Cardiology Immunology Radiology Monoclonal Antibodies Specialty Diagnostics
🏢Sanofi Aventis— Senior Executive Leadership
🏢Boehringer Mannheim— International Pharma Leadership
🏢Leading Local Pharma Groups— MD, COO & Director Marketing roles
⭐Salventis Pharma (SMC-Private) Limited— Founder & CEO · Islamabad (Current)
Our Portfolio
Discover Our Medicines

Three active therapeutic divisions — with Radiology expanding our capabilities. All products DRAP-registered, WHO-GMP sourced.

🧬 Oncology
💊 Urology
🏥 Critical Care
Radiology
❤️ Cardiology 2027
Oncology Division — Our flagship area. Zoledronic Acid products for bone metastases, hypercalcaemia of malignancy, and osteoporosis. Including Zolegen® (5mg/100ml) — our branded IV solution as per Innovators Specification.
💉 Oncology
Zoledronic Acid
Generic: Zoledronic Acid  |  4mg / 5ml  |  Vial

Bisphosphonate IV infusion for hypercalcaemia of malignancy, bone metastases from solid tumours, and multiple myeloma. WHO Essential Medicine.

Bone MetastasesHypercalcaemiaWHO EML
Enquire →
Zolegen®
Zolegen — Zoledronic Acid 5mg/100ml 3D box
Zolegen®
Generic: Zoledronic Acid  |  5mg / 100ml  |  Vial  |  Brand: Zolegen

Zoledronic Acid 5mg/100ml IV solution for infusion — post-menopausal osteoporosis, glucocorticoid-induced osteoporosis, and Paget's disease. Annual infusion. As per Innovators Specification.

OsteoporosisAnnual IV Infusion5mg / 100ml
Enquire →
Urology Division — Tamsulosin-based products for BPH management. Tamstone-D (combination) and Tamstone (monotherapy) serve urologists, GPs, and geriatric specialists across Pakistan.
Tamstone-D®
Tamstone-D® product packaging
Tamstone-D®
Generic: Tamsulosin + Dutasteride  |  0.4mg + 0.5mg  |  Capsule 20's

Fixed-dose combination alpha-1 blocker + 5α-reductase inhibitor for moderate-to-severe BPH. Dual Action, Real Relief — Restore Flow. Restore Life.

BPH CombinationTamstone-DSoft Gelatin Capsules
Enquire →
Tamstone®
Tamstone — Tamsulosin box
Tamstone®
Generic: Tamsulosin  |  0.4mg  |  Capsule 20's  |  Brand: Tamstone

Selective α1-adrenoceptor antagonist for LUTS associated with benign prostatic hyperplasia. Modified-release once-daily capsule for improved patient adherence and tolerability.

LUTS / BPHAlpha-1 SelectiveOnce Daily
Enquire →
Critical Care & Antibiotic Division — Hospital-grade IV antibiotics for ICU, emergency, and surgical settings. Meropenem (carbapenem) in two strengths and Tigradox (Tigecycline — glycylcycline reserve antibiotic).
💊Carbapenem IV
Meropenem 1g
Generic: Meropenem  |  1 gram  |  Vial

Broad-spectrum carbapenem antibiotic for hospital-acquired infections including HAP/VAP, complicated UTI, bacterial meningitis, septicaemia, and intra-abdominal infections. Last-resort MDR coverage.

HAI CoverageMDR OrganismsIV Injection
Enquire →
🔬Carbapenem IV
Meropenem 500mg
Generic: Meropenem  |  500mg  |  Vial

Half-strength carbapenem for paediatric dosing, renal dose adjustment, and surgical prophylaxis. Same broad-spectrum MDR Gram-negative coverage in a flexible dosage format.

PaediatricRenal AdjustmentIV Injection
Enquire →
Tigradox®
Tigradox® product packaging
Tigradox
Generic: Tigecycline  |  50mg injection  |  Vial  |  Brand: Tigradox

Reserve glycylcycline for MDR Gram-positive (MRSA), Gram-negative, and anaerobic organisms. Complicated skin/soft-tissue infections, CIAI, and community-acquired pneumonia.

MDR / MRSACIAI / CSSSIReserve Antibiotic
Enquire →
Radiology Division

Our flagship contrast imaging portfolio — featuring Iohexol — is launching in Q4 2026, expanding into diagnostic radiology across Pakistan's hospitals.

Launching Q4 2026 Register Interest →
❤️
Cardiology Division

Our cardiovascular portfolio is under active development. Launching 2027.

Coming 2027 Register Interest →
🏢
About Salventis

Our story, our mission, and the team behind Pakistan's forward-looking specialty pharma distributor.

Learn More →
💊
Solutions

Hospital procurement, distribution partnerships, and HCP engagement programmes across Pakistan.

Explore →
🔬
Innovation

Actively seeking partnerships in oncology, radiology, and specialty therapeutics including monoclonal antibodies.

Partner With Us →
📊
Investors & Media

Information for investors, media enquiries, and strategic collaborators interested in Salventis Pharma.

Get In Touch →
🌟 Purpose-Driven Work
🚀 Fast-Growing Company
🏥 Healthcare Impact
📍 Islamabad, Pakistan
👥
Join Our Team

Be part of a team changing healthcare access in Pakistan — one life-saving medicine at a time.

Join Our Team

Build Your Career in Specialty Pharma

At Salventis Pharma, we are building Pakistan's most trusted specialty pharmaceutical distributor. We are looking for passionate, science-driven professionals who share our commitment to improving patient outcomes and bringing innovative therapies to healthcare professionals across the country.

🎯
Purpose-Driven Mission
Every role contributes directly to patient access and healthcare outcomes
📈
Growth Opportunity
Be part of a fast-growing specialty pharma company from its foundation
🧬
Scientific Environment
Work with oncology, critical care, and specialty therapeutic portfolios
🤝
Expert Leadership
Learn from 45+ years of multinational pharmaceutical experience
Explore Opportunities →
🤝

Seeking Strategic Partnerships

Salventis Pharma is actively seeking collaborations with international and local pharmaceutical principals — particularly in oncology, radiology, and specialty therapeutics, including monoclonal antibodies and diagnostic imaging products.

Discuss a Partnership → Get In Touch
Industry News

Pharmaceutical Newsroom

Curated pharmaceutical and healthcare news relevant to our therapeutic areas. Click any article to read on the original source — updated regularly.

💊 Biopharma Live
📰 BioPharma Dive
Latest Drug Approvals & Pharmaceutical Industry News

Breaking news on FDA approvals, clinical trial results, oncology advances, and global biopharma industry developments — daily updates.

Daily Updates↗
🧬 Oncology & R&D
📰 Pharmaphorum
2026 Biopharma Trends: AI, Oncology & Cardiometabolic Advances

AI-driven drug development, advanced therapeutics, and cardiometabolic medicines dominate 2026 pipelines. Oncology and precision medicine at the forefront.

pharmaphorum.com↗
🔬 Antibiotics
📰 MDPI Antibiotics
Tigecycline & Meropenem: New 2026 Clinical Pharmacokinetic Data

New pharmacokinetic data on tigecycline and meropenem in ICU settings. Pakistan's AMR agenda highlights growing demand for reserve IV antibiotics.

MDPI Antibiotics 2026↗
More sources: BioPharma Dive ↗ NEJM ↗ The Lancet ↗ Pharmaphorum ↗ WHO Antibiotics ↗
Reach Us

Let's Start a Conversation

Hospital procurement, distribution partnerships, HCP enquiries, or investment discussions — we're ready to help.

Contact Information
📍
Head Office
Apt. A-3, 3rd Floor, Plaza No. 8
Civic Centre, Bahria Town Phase 4
Islamabad, Pakistan
📞
☎️
✉️
General Enquiries
info@salventispharma.com
✉️
🌐
Theme